A PHASE 2, OPEN-LABEL, SINGLE-ARM, TWO-COHORT STUDY OF NIVOLUMAB IN RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) OR RELAPSED/REFRACTORY PRIMARY TESTICULAR LYMPHOMA (PTL)

Registry ID

CA209-647

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

BRISTOL-MYERS SQUIBB CANADA

Start date

2017-07-14

Completion date

2022-06-22

Last update

2016-09-26

Conditions

• CENTRAL NERVOUS SYSTEM LYMPHOMA
• TESTICULAR LYMPHOMA

Related clinical trials

• A PHASE 2 STUDY OF IBRUTINIB COMBINATION THERAPY IN TRANSPLANT INELIGIBLE INDIVIDUALS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

View on source registry